The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGateley Holdings Regulatory News (GTLY)

Share Price Information for Gateley Holdings (GTLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.50
Bid: 120.00
Ask: 121.00
Change: 0.50 (0.42%)
Spread: 1.00 (0.833%)
Open: 120.50
High: 121.00
Low: 120.50
Prev. Close: 120.00
GTLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Share Option Plan - Issue of Equity

8 Nov 2021 07:00

RNS Number : 5559R
Gateley (Holdings) PLC
08 November 2021
 

8 November 2021

GATELEY (HOLDINGS) PLC

("Gateley", the "Company" or the "Group")

Company Share Option Plan Issue of Equity

72% of current staff are now existing share or option holders in the Group

Gateley (AIM: GTLY), the legal and professional services group, announces that 447,494 ordinary shares of 10p each in Gateley ("Ordinary Shares") have been issued, pursuant to the Group's Company Share Option Plan ("CSOP") scheme introduced in 2018 and as a result of vesting conditions being satisfied. In addition, the Company has allotted 168,044 Ordinary Shares under its existing block listing for the 2018 SAYE Scheme (the "SAYE Allotment").

The Board remains committed to maintaining Group-wide share ownership as a means of incentivisation which also creates strong alignment with external shareholders. This is reflective of the Group's long-established culture, which remains central to its success and aligns with Gateley's recently published Responsible Business Report which outlines commitments to the achievement of Levelling-up goals for employees. The report can be accessed via this link.

Further, the Board believes that the opportunity for share ownership is a valuable differentiator for Gateley as an alternative to traditional professional services ownership and incentivisation models.

Since flotation, the Group has established a number of share-based schemes including SAYE, CSOP and LTIP that variously offer all staff the ability to participate in early ownership of Gateley and share in the rewards of that ownership as they contribute to the success of the Group. 72% of current staff are now existing share or option holders in the Group.

Full details of the Group's share-based incentive schemes are set out in the Annual Report, which can be found on the Group's website and accessed via this link.

Total Voting Rights

Application has been made for 447,494 new Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 9 November 2021. Following Admission and the SAYE Allotment, the Company will have a total of 119,153,923 Ordinary Shares in issue with one voting right per share.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Gateley (Holdings) Plc

Neil Smith, Finance Director

Tel: +44 (0) 121 234 0196

Nick Smith, Acquisitions Director and Head of Investor Relations

Tel: +44 (0) 20 7653 1665

Cara Zachariou, Head of Corporate Communications

Tel: +44 (0) 121 234 0074

Mob: +44 (0) 7703 684 946

Liberum - Nominated adviser and Broker

Richard Lindley / Ben Cryer / Cara Murphy

Tel: +44 (0) 20 3100 2000

Belvedere Communications Limited - Financial PR

Cat Valentine (cvalentine@belvederepr.com)

Mob: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Mob: +44 (0) 7967 816 525

Llew Angus (langus@belvederepr.com)

Mob: +44 (0) 7407 023 147

gateleypr@belvederepr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUVVNRANUARAA
Date   Source Headline
5th Apr 20247:00 amRNSEBT Share Purchase / PDMR Dealings
18th Jan 20247:00 amRNSShare Purchase by Incoming Non-Executive Director
17th Jan 20247:00 amRNSSuccession Update: Appointment of Chair Designate
17th Jan 20247:00 amRNSHalf Year Results
22nd Nov 20237:00 amRNSH1 24 Trading update and notice of results
15th Nov 20234:28 pmRNSTR-1
14th Nov 20231:33 pmRNSGrant of SAYE Options and PDMR Dealings
31st Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20237:01 amRNSResult of AGM
25th Sep 20237:30 amRNSNotice of AGM
22nd Sep 20234:41 pmRNSTR-1
22nd Sep 20234:11 pmRNSBlock listing Six Monthly Review
21st Sep 20232:40 pmRNSShare Awards and Options, Issue of Equity and TVR
15th Sep 20237:00 amRNSPublication of annual Responsible Business report
14th Sep 20237:00 amRNSHolding(s) in Company
11th Sep 20235:00 pmRNSTR-1
8th Sep 20232:56 pmRNSAudited Results 2023 Replacement
6th Sep 20238:51 amRNSTR-1
6th Sep 20237:00 amRNSAppointment of Non-Executive Director
6th Sep 20237:00 amRNSAudited Results 2023
31st Aug 20237:00 amRNSNotice of Final Results
31st Jul 20237:00 amRNSYear end update & notice of annual results and AGM
20th Jul 20237:00 amRNSAcquisition of Richard Julian and Associates Ltd
27th Jun 202310:31 amRNSBoard Change
2nd Jun 20237:00 amRNSFY23 Trading Update
25th May 20239:26 amRNSTR-1
11th May 20232:16 pmRNSTR-1
7th Mar 20232:46 pmRNSTR-1
23rd Feb 20239:37 amRNSGrant of Share Awards, Share Options and TVR
18th Jan 20237:00 amRNSHalf Year Results
16th Jan 20232:04 pmRNSTR-1
12th Dec 20228:00 amRNSSecond Responsible Business Report
24th Nov 20227:00 amRNSTrading update and notice of results
1st Nov 20221:40 pmRNSIssue of Equity, Block Listing and TVRs
20th Oct 20224:02 pmRNSResult of AGM
4th Oct 20227:00 amRNSAcquisition of Symbiosis IP, Issue of Equity & TVR
3rd Oct 20225:14 pmRNSTR-1
26th Sep 20228:00 amRNSNotice of AGM
14th Sep 20227:00 amRNSIssue of Equity and Total Voting Rights
13th Sep 20227:00 amRNSAudited Preliminary Results 2022
5th Sep 20227:00 amRNSNotice of Results and Online Presentations
13th Jun 20227:00 amRNSFY22 Trading Update - Ahead of Expectations
3rd May 20221:22 pmRNSPlanned Succession Board Changes
3rd May 20221:05 pmRNSTR-1
28th Apr 202212:58 pmRNSNew Share Award Plan, Grant of Options and TVR
20th Apr 20227:00 amRNSAcquisition of Smithers Purslow
19th Apr 20229:52 amRNSNew Revolving Credit Facility agreed for £30m
18th Jan 202211:11 amRNSCorrection: Half Year Results to 31 October 2021
12th Jan 20227:00 amRNSHalf Year Results to 31 October 2021
10th Jan 20227:00 amRNSAcquisition of Adamson Jones Holdings Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.